Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Journal of Neuro-Oncology|June 20, 2020
Melanoma brain metastases: is it time to eliminate radiotherapy?Richard J White, Stephen Abel, Zachary D Horne, et al.
Practical Radiation Oncology|September 24, 2017
Standardization of nodal radiation therapy through changes to a breast cancer clinical pathway throughout a large, integrated cancer center networkBrian J Gebhardt, Joel Thomas, Zachary D Horne, et al.
Cancer|April 26, 2016
Confirmation of proposed human papillomavirus risk-adapted staging according to AJCC/UICC TNM criteria for positive oropharyngeal carcinomasZachary D Horne, Scott M Glaser, John A Vargo, et al.
Journal of Radiosurgery and SBRT|August 18, 2020
Adaptation of a Gamma Knife Icon stereotactic radiosurgery program in the face of the COVID-19 pandemicRodney E Wegner, Zachary D Horne, Linda Xu, et al.
Advances in Radiation Oncology|October 14, 2021
Single Fraction Frameless Stereotactic Radiosurgery on the Gamma Knife Icon for Patients With Brain Metastases: Time to Abandon the Frame?Rodney E Wegner, Zachary D Horne, Yun Liang, et al.
Brachytherapy|May 17, 2021
Intraprostatic calcification and biochemical recurrence in men treated with cesium-131 prostate brachytherapyMichael D Schad, Joshua L Rodríguez-López, Ankur K Patel, et al.
Frontiers in Oncology|October 27, 2015
Treatment Plan Technique and Quality for Single-Isocenter Stereotactic Ablative Radiotherapy of Multiple Lung Lesions with Volumetric-Modulated Arc Therapy or Intensity-Modulated RadiosurgeryKimmen Quan, Karen M Xu, Ron Lalonde, et al.
Frontiers in Oncology|January 27, 2023
Expert guidance on prophylaxis and treatment of dermatologic adverse events with Tumor Treating Fields (TTFields) therapy in the thoracic regionMilan J Anadkat, Mario Lacouture, Adam Friedman, et al.
Gynecologic Oncology|May 11, 2024
Clinical outcomes with utilization of high-potency topical steroids in patients with lichen sclerosus-associated vulvar cancerNujsaubnusi C Vue, Jessica Sassani, Beth Prairie, et al.
Lung Cancer (Amsterdam, Netherlands)|June 16, 2019
Optimal adjuvant therapy in clinically N2 non-small cell lung cancer patients undergoing neoadjuvant chemotherapy and surgery: The importance of pathological response and lymph node ratioAshwin Shinde, Zachary D Horne, Richard Li, et al.
Pageof 6